Literature DB >> 33413671

AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL.

Zuoqiao Wu1,2, Mary Nicoll1,3, Robert J Ingham4.   

Abstract

Classical Hodgkin lymphoma (cHL) and anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma (ALK+ ALCL) are B and T cell lymphomas respectively, which express the tumour necrosis factor receptor superfamily member, CD30. Another feature shared by cHL and ALK+ ALCL is the aberrant expression of multiple members of the activator protein-1 (AP-1) family of transcription factors which includes proteins of the Jun, Fos, ATF, and Maf subfamilies. In this review, we highlight the varied roles these proteins play in the pathobiology of these lymphomas including promoting proliferation, suppressing apoptosis, and evading the host immune response. In addition, we discuss factors contributing to the elevated expression of these transcription factors in cHL and ALK+ ALCL. Finally, we examine therapeutic strategies for these lymphomas that exploit AP-1 transcriptional targets or the signalling pathways they regulate.

Entities:  

Keywords:  ALK+ ALCL; Activator protein-1; CD30; Hodgkin; Lymphoma

Year:  2021        PMID: 33413671      PMCID: PMC7792353          DOI: 10.1186/s40164-020-00197-9

Source DB:  PubMed          Journal:  Exp Hematol Oncol        ISSN: 2162-3619


  149 in total

1.  Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy.

Authors:  Michael R Green; Scott Rodig; Przemyslaw Juszczynski; Jing Ouyang; Papiya Sinha; Evan O'Donnell; Donna Neuberg; Margaret A Shipp
Journal:  Clin Cancer Res       Date:  2012-01-23       Impact factor: 12.531

2.  Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR.

Authors:  Amanda Dutton; Gary M Reynolds; Christopher W Dawson; Lawrence S Young; Paul G Murray
Journal:  J Pathol       Date:  2005-03       Impact factor: 7.996

Review 3.  Activation and function of immediate-early genes in the nervous system.

Authors:  Beatriz Pérez-Cadahía; Bojan Drobic; James R Davie
Journal:  Biochem Cell Biol       Date:  2011-02       Impact factor: 3.626

Review 4.  AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration.

Authors:  T Herdegen; V Waetzig
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 5.  Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  D A Eichenauer; B M P Aleman; M André; M Federico; M Hutchings; T Illidge; A Engert; M Ladetto
Journal:  Ann Oncol       Date:  2020-01-07       Impact factor: 32.976

6.  Reed-Sternberg cell-derived lymphotoxin-α activates endothelial cells to enhance T-cell recruitment in classical Hodgkin lymphoma.

Authors:  Chee Wai Fhu; Anne M Graham; Celestial T Yap; Suhail Al-Salam; Antonio Castella; Siew Meng Chong; Yaw-Chyn Lim
Journal:  Blood       Date:  2014-08-19       Impact factor: 22.113

Review 7.  Targeting inflammation by modulating the Jun/AP-1 pathway.

Authors:  Helia B Schonthaler; Juan Guinea-Viniegra; Erwin F Wagner
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

8.  Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun.

Authors:  R Chiu; P Angel; M Karin
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

9.  Structure/function analysis of the murine CD95L promoter reveals the identification of a novel transcriptional repressor and functional CD28 response element.

Authors:  Scott A Crist; Thomas S Griffith; Timothy L Ratliff
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

10.  A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma.

Authors:  Chengsheng Wu; Hai-Feng Zhang; Nidhi Gupta; Abdulraheem Alshareef; Qian Wang; Yung-Hsing Huang; Jamie T Lewis; Donna N Douglas; Norman M Kneteman; Raymond Lai
Journal:  J Hematol Oncol       Date:  2016-11-08       Impact factor: 17.388

View more
  5 in total

1.  EGR1 Upregulation during Encephalitic Viral Infections Contributes to Inflammation and Cell Death.

Authors:  Caitlin W Lehman; Amy Smith; Jamie Kelly; Jonathan L Jacobs; Jonathan D Dinman; Kylene Kehn-Hall
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

Review 2.  Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties.

Authors:  Daniela Carlisi; Marianna Lauricella; Antonella D'Anneo; Anna De Blasio; Adriana Celesia; Giovanni Pratelli; Antonietta Notaro; Giuseppe Calvaruso; Michela Giuliano; Sonia Emanuele
Journal:  Biomedicines       Date:  2022-02-21

3.  Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma.

Authors:  Xiaonan Zhou; Shizhu Guo; Yonghong Shi
Journal:  Sci Rep       Date:  2022-02-18       Impact factor: 4.379

Review 4.  Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma.

Authors:  Yuan Wang; Jing He; Manyu Xu; Qingfeng Xue; Cindy Zhu; Juan Liu; Yaping Zhang; Wenyu Shi
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

5.  RNA Sequencing of Primary Cutaneous and Breast-Implant Associated Anaplastic Large Cell Lymphomas Reveals Infrequent Fusion Transcripts and Upregulation of PI3K/AKT Signaling via Neurotrophin Pathway Genes.

Authors:  Arianna Di Napoli; Davide Vacca; Giorgio Bertolazzi; Gianluca Lopez; Maria Piane; Aldo Germani; Evelina Rogges; Giuseppina Pepe; Fabio Santanelli Di Pompeo; Marzia Salgarello; Vaidehi Jobanputra; Susan Hsiao; Kazimierz O Wrzeszczynski; Emilio Berti; Govind Bhagat
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.